Tuan Sing Limited: Credit Outlook Anchored by Asset Quality Amid Elevated Leverage

 |   29 Jan 2026  |    6 views

Company Overview

Tuan Sing is a Singapore-listed real estate and hospitality group with activities spanning real estate investment, hospitality operations, and property development, with key exposure to Singapore, Australia, and Indonesia. The group is majority owned by Nuri Holdings (S) Pte Ltd (54.5%), a family office for the Liem family, with Michelle Liem and William Liem as key decision-makers.


1H25 Credit Performance Highlights

Tuan Sing has meaningful assets backing, but leverage keeps balance-sheet buffers thin. Total assets were S$2.71bn with equity of about S$1.20bn as at 1H25, providing a base level of loss absorption and some refinancing flexibility. However, leverage remains elevated, with net debt to equity at 1.01x and total debt to total assets at 0.50x, while total debt of S$1.35bn compares with cash of S$143mn. This limits tolerance for valuation swings or earnings shocks and keeps credit comfort sensitive to liquidity headroom.

The near-term earnings drag is transition-driven, with improvement expected as assets stabilise and AEI benefits season through. 1H25 showed a clearer YoY improvement versus 1H24, supported by the completion of Dunearn Village, while Langley Park is expected to contribute higher recurring cash flows as leasing and operations normalise. Management is guiding for EBIT and cash flow to improve from 2026, implying a more resilient recurring earnings base that should gradually reduce reliance on episodic development outcomes.

However, execution risk remains front and centre, given the long-dated uplift from Melbourne Collins Street, even as liability management is improving. The group has secured the planning permit for the redevelopment of Collins Street in Melbourne, comprising Grand Hyatt Melbourne and retail, with completion targeted in 2028. Management also guiding for rental escalation above current in-place rents supported by premium and luxury tenanting and destination F&B, which is supportive for end-state valuation, but the credit impact is back-ended and depends on disciplined capex phasing and disruption control through the build period.

On the funding side, management indicated ongoing refinancing into a 3-4 year maturity bucket, which should reduce near-term maturity concentration and improve visibility during execution. Separately, the broader pipeline offers upside optionality, with Opus Bay in Batam supported by improving connectivity, including the Batam airport development, and Tuan Sing’s ownership of the Teluk Senimba Ferry Terminal strengthens ecosystem demand; with land cost effectively zero, development can be phased alongside take-up, supporting a more controllable cash investment profile.

Moving forward, the first watchpoint is whether coverage meaningfully rebuilds into 2026, through a sustained uplift in recurring EBIT or EBITDA that creates a durable interest buffer and reduces reliance on refinancing or asset sales. The second is Melbourne execution into 2028, specifically capex phasing, cost containment, disruption management, and leasing traction consistent with the rental escalation and premium-brand tenanting assumptions; any slippage would extend the period of tight liquidity and covenant sensitivity.


Credit view: We are cautiously positive on Tuan Sing’s outlook. Management’s guidance for earnings and cash flow to improve from 2026, alongside normalising transitions and AEI benefits, is credit supportive, and refinancing actions should reduce near-term maturity pressure. However, with leverage already elevated and the Melbourne uplift back-ended, credit comfort remains most sensitive to liquidity discipline and covenant buffers over the execution period, making delivery and funding management the key determinants of spread performance.


Overview of Tuan Sing’s Outstanding SGD Bonds

Factsheets


Related Articles

Perennial Holdings: Strengthening Healthcare Platform Supports Gradual Credit Improvement

Perennial Holdings is an integrated real estate and healthcare company headquartered in Singapore, with operations spanning China, Singapore, Malaysia, and Ghana.

 |   30 Jan 2026

Keppel REIT: Prime CBD Franchise and Leasing Momentum Support a Stable BBB Credit

Keppel REIT is a Singapore-listed REIT with a S$9.5bn portfolio value of predominantly Grade-A office assets across Singapore (78%), Australia (18%), South Korea (3%), and Japan (1%).

 |   30 Jan 2026

Aspial Lifestyle: Improved Earnings, but High Leverage and Working-Capital Drag Keep Credit Neutral

Aspial Lifestyle is a consumer lifestyle group operating across Singapore, Malaysia, and Hong Kong, with businesses in jewellery retail, pawnbroking, and secured lending.

 |   30 Jan 2026

Disclaimers


These commentaries are intended for general circulation. It does not have regard to the specific investment objectives, financial situation and particular needs of any person who may receive this document. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of the units and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. Investors may wish to seek advice from a financial adviser before investing. In the event that investors choose not to seek advice from a financial adviser, they should consider whether the investment is suitable for them.

The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the "Research") contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.

Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com

?>